Design
Review
Authors
Loading...
Supports membrane guanylate cyclase as ANP receptor; leaves open targeted HF therapies.
Key points are not available for this paper at this time.
Schulz et al. (1989) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: